With the passing of Executive Order 13505,
Removing Barriers to Responsible Scientific Research Involving Human Stem Cells, in 2009 President Obama expanded federal funding and rescinded
George W. Bush's policies that eliminated most federal funding and restricted
human embryonic stem cell research to the use of existing, contaminated cell lines. On Monday, federal judge Royce C. Lamberth
blocked this new order after protestations from James L. Sherley, a former scientist with the Boston Biomedical Research Institute, and Theresa Deisher, who operates the
Ave Maria Biotechnology Company, which aims to do "pro-life" therapeutic research without the "taint of embryonic or electively aborted fetal materials".
Both plaintiffs have a history of opposition to embryonic stem cell research. Sherley coined the term "
embryoism", to describe discrimination "against human embryos, just like there is discrimination against people of different culture and races." His objection to embryonic stem cell research in this case rested with competition for grant dollars, and damages he would suffer from funding that would not be given to his adult stem cell research projects. Deisher's objections also lied with the similar inability to compete for grant dollars with this new policy in place. Adult stem cells are taken from the tissues of a developed (adult) human being, with a somewhat lesser capability for
pluripotency than embryonic stem cells, which have the ability to differentiate into all other tissue types and are, as a result, more attractive than adult cells as therapeutic agents.
While new, legitimate research grants will go unfunded and applications unprocessed until the crisis is resolved, the National Institutes for Health, for its part, might continue with funding existing stem cell research grants and will hold a review with major primary investigators next Tuesday. The Department of Justice also
plans to appeal Lamberth's ruling.
posted by GuyZero at 3:16 PM on August 25, 2010 [5 favorites]